Long Non-coding RNA MVIH is Associated with Poor Prognosis and Malignant Biological Behavior in Breast Cancer

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2015 Nov 12

PMID 26555546

Citations 26

Authors

Bo Lei

Shou-Ping Xu

Xiao-Shuan Liang

Yi-Wen Li

Jin-Feng Zhang

Guo-Qiang Zhang

Da Pang

Affiliations

Soon will be listed here.

Abstract

In recent years, with the development of transcriptomics, the effect of long non-coding RNAs (LncRNAs) on the regulation of biological processes is being elucidated. LncRNAs play an important role in tumor occurrence and development. LncRNA associated with microvascular invasion in hepatocellular carcinoma (LncRNA MVIH) was first identified in hepatocellular carcinoma and is associated with angiogenesis, tumor growth and metastasis upregulation, and poor recurrence-free survival. MVIH has an important role in non-small cell lung cancer, in which it promotes cell proliferation and metastasis, and high MVIH expression indicates poor overall survival. However, the involvement of MVIH in breast cancer is unclear. Our research revealed that the expression levels of MVIH in breast cancer tissues were higher than in adjacent noncancerous tissues, and high MVIH expression was correlated with Ki67 expression. Moreover, breast cancer patients with high MVIH expression levels showed poor overall survival and disease-free survival. Multivariate analysis results indicated that MVIH was an independent prognostic factor in breast cancer. In addition, upregulated MVIH expression levels promoted cell proliferation and cell cycle, and inhibited cell apoptosis, while reduced MVIH expression showed the converse. In summary, our findings suggest that MVIH may have an important role in breast cancer and may serve as a new biomarker and a potential therapeutic target.

Citing Articles

Relationship between long non-coding RNAs and Hippo signaling pathway in gastrointestinal cancers; molecular mechanisms and clinical significance.

Fayyaz F, Shokati Eshkiki Z, Karamzadeh A, Moradi Z, Kaviani F, Namazi A Heliyon. 2024; 10(1):e23826.

PMID: 38226210 PMC: 10788524. DOI: 10.1016/j.heliyon.2023.e23826.

The role of mitochondrial/metabolic axis in development of tamoxifen resistance in breast cancer.

Azzam H, El-Derany M, Wahdan S, Faheim R, Helal G, El-Demerdash E Hum Cell. 2023; 36(6):1877-1886.

PMID: 37646973 PMC: 10587280. DOI: 10.1007/s13577-023-00977-5.

Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis.

Bahramy A, Zafari N, Rajabi F, Aghakhani A, Jayedi A, Khaboushan A Front Mol Biosci. 2023; 10:1096524.

PMID: 36726376 PMC: 9885171. DOI: 10.3389/fmolb.2023.1096524.

Ectopic expression of lncRNA MVIH as a potential diagnostic biomarker in cervical cancer.

Ghanbari M, Aghazadeh A, Malekabbaslou E, Rajabi A, Sobhkhizy A, Maydanchi M Genes Cancer. 2022; 13:52-59.

PMID: 36471781 PMC: 9718588. DOI: 10.18632/genesandcancer.224.

knockdown inhibits the malignancy progression through downregulating mediated and in acute myeloid leukemia.

Ke S, Zhou X Transl Cancer Res. 2022; 8(7):2526-2534.

PMID: 35117009 PMC: 8799070. DOI: 10.21037/tcr.2019.10.12.

References

Vennin C, Spruyt N, Dahmani F, Julien S, Bertucci F, Finetti P . H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget. 2015; 6(30):29209-23. PMC: 4745721. DOI: 10.18632/oncotarget.4976. View

Yang F, Zhang L, Huo X, Yuan J, Xu D, Yuan S . Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology. 2011; 54(5):1679-89. DOI: 10.1002/hep.24563. View

Mourtada-Maarabouni M, Pickard M, Hedge V, Farzaneh F, Williams G . GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2008; 28(2):195-208. DOI: 10.1038/onc.2008.373. View

Jonsson P, Coarfa C, Mesmar F, Raz T, Rajapakshe K, Thompson J . Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant lncRNAs in Breast Cancer. Mol Endocrinol. 2015; 29(11):1634-45. PMC: 4627604. DOI: 10.1210/me.2015-1153. View

Gutschner T, Diederichs S . The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012; 9(6):703-19. PMC: 3495743. DOI: 10.4161/rna.20481. View

Wan G, Hu X, Liu Y, Han C, Sood A, Calin G . A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation. EMBO J. 2013; 32(21):2833-47. PMC: 3817469. DOI: 10.1038/emboj.2013.221. View

Liu R, Li J, Lai Y, Liao Y, Liu R, Qiu W . Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1. Int J Biol Macromol. 2015; 81:491-7. DOI: 10.1016/j.ijbiomac.2015.08.016. View

Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M . Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis. 2014; 5:e1008. PMC: 4040676. DOI: 10.1038/cddis.2013.541. View

Prensner J, Chen W, Iyer M, Cao Q, Ma T, Han S . PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer. Cancer Res. 2014; 74(6):1651-60. PMC: 4009928. DOI: 10.1158/0008-5472.CAN-13-3159. View

10.

DeSantis C, Ma J, Bryan L, Jemal A . Breast cancer statistics, 2013. CA Cancer J Clin. 2013; 64(1):52-62. DOI: 10.3322/caac.21203. View

11.

Nie F, Zhu Q, Xu T, Zou Y, Xie M, Sun M . Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion. Tumour Biol. 2014; 35(8):7587-94. DOI: 10.1007/s13277-014-2009-7. View

12.

Xu S, Zhang J, Sui S, Bai N, Gao S, Zhang G . Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer. Tumour Biol. 2015; 36(12):9807-12. DOI: 10.1007/s13277-015-3746-y. View

13.

Zhou M, Hou Y, Yang G, Zhang H, Tu G, Du Y . LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway. Stem Cells. 2015; 34(1):55-66. PMC: 4832137. DOI: 10.1002/stem.2219. View

14.

Tian X, Xu G . Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis. BMJ Open. 2015; 5(9):e008653. PMC: 4593150. DOI: 10.1136/bmjopen-2015-008653. View

15.

Xie M, Sun M, Zhu Y, Xia R, Liu Y, Ding J . Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression. Oncotarget. 2015; 6(32):33587-601. PMC: 4741787. DOI: 10.18632/oncotarget.5599. View

16.

Li X, Wu Z, Fu X, Han W . lncRNAs: insights into their function and mechanics in underlying disorders. Mutat Res Rev Mutat Res. 2014; 762:1-21. DOI: 10.1016/j.mrrev.2014.04.002. View

17.

Yuan S, Yang F, Yang Y, Tao Q, Zhang J, Huang G . Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology. 2012; 56(6):2231-41. DOI: 10.1002/hep.25895. View

18.

Zhang A, Zhao J, Kim J, Fong K, Yang Y, Chakravarti D . LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer. Cell Rep. 2015; 13(1):209-221. PMC: 4757469. DOI: 10.1016/j.celrep.2015.08.069. View

19.

Zhao Z, Li S, Song E, Liu S . The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells. Protein Cell. 2015; 7(2):89-99. PMC: 4742390. DOI: 10.1007/s13238-015-0199-4. View

20.

Xue X, Yang Y, Zhang A, Fong K, Kim J, Song B . LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogene. 2015; 35(21):2746-55. PMC: 4791209. DOI: 10.1038/onc.2015.340. View